A Clinical Survey on Bladder Tumor.
- Author:
Suck Chill KIM
1
;
Dong Han KIM
Author Information
1. Department of Urology, College of Medicine, Han yang University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
bladder tumor;
transitional cell carcinoma
- MeSH:
Carcinoma, Transitional Cell;
Cystectomy;
Drug Therapy;
Female;
Follow-Up Studies;
Hematuria;
Humans;
Male;
Recurrence;
Sex Ratio;
Urinary Bladder Neoplasms*;
Urinary Bladder*;
Urinary Diversion;
Urinary Tract;
Urology
- From:Korean Journal of Urology
1983;24(2):273-280
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A clinical survey was made on 90 cases of bladder tumor admitted to the Department of Urology. Hanyang University Hospital during the period from May, 1972 to April, 1982. The following results were obtained: 1. During the period, 2,679 patients were hospitalized, there were 90 cases of bladder tumor giving a rate of 3.4%. 2. The sex ratio was 5:1 with 75 male and 15 female, and 71.1% of the cases were in the age group of 41-70. 3. Hematuria was the most common symptom and occurred in 83.3%. 4. 70% of the cases visited the hospital within 1 year after the occurrence of the initial symptom. 5. Among 76 cases in which IVP was performed, 68.4% of the cases revealed normal upper urinary tract, and filling defect in the bladder were observed in 60.5% of the cases. 6. In the majority of case the tumor was located on the inside of the lateral wall of the bladder (67.8%) 64.4% of all cases had multiple lesions. 7. On pathological examination, 94.4% were transitional cell carcinomas and Grade II was the most frequent finding. 8. Initial treatment was given for 65 of the 90 cases of bladder tumor. TUR operation were performed in 9 cases, open resection and electrofulguration in 10 cases, partial cystectomy in 16 cases and total cystectomy with urinary diversion in 7 cases. Operation with chemotherapy or radiation therapy were performed in 17 cases, intravesical chemotherapy and radiation therapy were used in 2 cages each and systemic chemotherapy and radiation with chemotherapy were uses in 1 case each. 9. Average duration of follow up was about 15.8 months. 10. First recurrence percentage was 42.8.